Monthly Archives: January 2025

• 

Belzutifan approved in Europe for advanced kidney cancer and VHL disease

By Sharon Deveson Kell|2025-01-24T10:28:46+00:0024 Jan 2025|Drug treatments|

The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for [...]

Read More

Comments Off on Belzutifan approved in Europe for advanced kidney cancer and VHL disease

• 

Belzutifan plus cabozantinib combination shows promise in advanced kidney cancer

By Sharon Deveson Kell|2025-01-22T11:02:35+00:0022 Jan 2025|Drug treatments|

Updated results from the phase 2 LITESPARK-003 trial with belzutifan [...]

Read More

Comments Off on Belzutifan plus cabozantinib combination shows promise in advanced kidney cancer

• 

Promising new combination therapy for advanced kidney cancer

By Sharon Deveson Kell|2025-01-20T11:28:45+00:0020 Jan 2025|Drug treatments|

Combinations of tyrosine kinase inhibitors plus immunotherapy have improved treatment [...]

Read More

Comments Off on Promising new combination therapy for advanced kidney cancer

• 

NHS England’s Elective Care Reform Plan

By Sharon Deveson Kell|2025-01-09T08:38:03+00:009 Jan 2025|Cancer news|

On 6 January 2025, NHS England launched their plan to [...]

Read More

Comments Off on NHS England’s Elective Care Reform Plan

• 

FDA approves injectable form of nivolumab

By Sharon Deveson Kell|2025-01-08T09:01:12+00:008 Jan 2025|Drug treatments|

Just after Christmas, the US Food and Drug Administration (FDA) [...]

Read More

Comments Off on FDA approves injectable form of nivolumab

• 

NHS Help Us, Help You campaign

By Sharon Deveson Kell|2025-01-08T09:04:35+00:006 Jan 2025|Uncategorized|

We know that many people worry about cancer but sometimes [...]

Read More

Comments Off on NHS Help Us, Help You campaign